Growth Hormone Deficiency (GHD) Latest Advances

The strategies of orthodontic treatment in children with growth hormone deficiency.

Journal: Annals of agricultural and environmental medicine : AAEM

Published: December 31, 2025

Diagnostic Value of Peak-to-Basal Difference or Ratio of Growth Hormone in Children with Growth Hormone Deficiency.

Journal: Journal of clinical research in pediatric endocrinology

Published: December 30, 2025

Adaptation and validation of the Mexican Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).

Journal: Gaceta medica de Mexico

Published: December 26, 2025

Reversible Injection-Site Lipoatrophy Induced by Long-Acting Growth Hormone (Somatrogon) in Pediatric Growth Hormone Deficiency: A Case Series.

Journal: Journal of clinical research in pediatric endocrinology

Published: November 20, 2025

Auxological parameters associated with the diagnosis of growth hormone deficiency in children with short stature.

Journal: Pediatric endocrinology, diabetes, and metabolism

Published: November 13, 2025

Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.

Journal: Endocrine journal

Published: November 03, 2025

A pharmacological profile of somapacitan for the treatment of growth hormone deficiency.

Journal: Expert review of clinical pharmacology

Published: October 31, 2025

Identification of a Novel Nonsense Mutation in the IGSF1 Gene Reveals Sex-Specific Phenotypic Variability Within a Single Family.

Journal: Children (Basel, Switzerland)

Published: October 24, 2025

IGF-I bioavailability in congenital isolated growth hormone deficiency.

Journal: European journal of endocrinology

Published: October 21, 2025

Growth Hormone Withdrawal in Mid-Puberty: No Impact on Near Adult Height in Adolescents with Transient Idiopathic GHD.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 15, 2025

Safety and efficacy of somapacitan in adults with growth hormone deficiency who were switched from daily growth hormone therapy: A systematic review and meta-analysis.

Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society

Published: October 07, 2025

Delphi-based Spanish consensus on the use of long-acting growth hormone in pediatric growth hormone deficiency: recommendations from the ConverGHe Working Group.

Journal: Frontiers in endocrinology

Published: October 03, 2025

Growth Hormone Deficiency (GHD) Latest Advances

Find the Latest Research About Growth Hormone Deficiency (GHD)

The strategies of orthodontic treatment in children with growth hormone deficiency.

The strategies of orthodontic treatment in children with growth hormone deficiency.

Diagnostic Value of Peak-to-Basal Difference or Ratio of Growth Hormone in Children with Growth Hormone Deficiency.

Diagnostic Value of Peak-to-Basal Difference or Ratio of Growth Hormone in Children with Growth Hormone Deficiency.

Adaptation and validation of the Mexican Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).

Adaptation and validation of the Mexican Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).

Reversible Injection-Site Lipoatrophy Induced by Long-Acting Growth Hormone (Somatrogon) in Pediatric Growth Hormone Deficiency: A Case Series.

Reversible Injection-Site Lipoatrophy Induced by Long-Acting Growth Hormone (Somatrogon) in Pediatric Growth Hormone Deficiency: A Case Series.

Auxological parameters associated with the diagnosis of growth hormone deficiency in children with short stature.

Auxological parameters associated with the diagnosis of growth hormone deficiency in children with short stature.

Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.

Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.

A pharmacological profile of somapacitan for the treatment of growth hormone deficiency.

A pharmacological profile of somapacitan for the treatment of growth hormone deficiency.

Identification of a Novel Nonsense Mutation in the IGSF1 Gene Reveals Sex-Specific Phenotypic Variability Within a Single Family.

Identification of a Novel Nonsense Mutation in the IGSF1 Gene Reveals Sex-Specific Phenotypic Variability Within a Single Family.

IGF-I bioavailability in congenital isolated growth hormone deficiency.

IGF-I bioavailability in congenital isolated growth hormone deficiency.

Growth Hormone Withdrawal in Mid-Puberty: No Impact on Near Adult Height in Adolescents with Transient Idiopathic GHD.

Growth Hormone Withdrawal in Mid-Puberty: No Impact on Near Adult Height in Adolescents with Transient Idiopathic GHD.

Safety and efficacy of somapacitan in adults with growth hormone deficiency who were switched from daily growth hormone therapy: A systematic review and meta-analysis.

Safety and efficacy of somapacitan in adults with growth hormone deficiency who were switched from daily growth hormone therapy: A systematic review and meta-analysis.

Delphi-based Spanish consensus on the use of long-acting growth hormone in pediatric growth hormone deficiency: recommendations from the ConverGHe Working Group.

Delphi-based Spanish consensus on the use of long-acting growth hormone in pediatric growth hormone deficiency: recommendations from the ConverGHe Working Group.